Metabolic Solutions Development Company, LLC
Records under this name other than the patents Metabolic Solutions Development Company, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 10 of 10 · Back to Metabolic Solutions Development Company, LLC
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,067,450 | Thiazolidinedione Analogues for the Treatment of Metabolic Diseases Formerly held In force · High confidence | In force | High confidence | |
| US 8,304,441 | Thiazolidinedione Analogues for the Treatment of Metabolic Diseases Formerly held In force · High confidence | In force | High confidence | |
| US 9,126,959 | Ppar-Sparing Thiazolidinedione Salts for the Treatment of Metabolic Diseases Formerly held In force · High confidence | In force | High confidence | |
| US 8,912,335 | Ppar-Sparing Thiazolidinedione Salts for the Treatment of Metabolic Diseases Formerly held In force · High confidence | In force | High confidence | |
| US 8,937,182 | Novel Synthesis for Thiazolidinedione Compounds Formerly held In force · High confidence | In force | High confidence | |
| US 8,933,240 | Novel Synthesis for Thiazolidinedione Compounds Formerly held In force · High confidence | In force | High confidence | |
| US 9,562,012 | PPAR-sparing compounds for the treatment of metabolic diseases Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,629,159 | Thiazolidinedione Analogues Lapsed on the fee record Ended Jan 14, 2026 · Low confidence | Lapsed on the fee record | Ended Jan 14, 2026 | Low confidence |
| US 8,389,556 | Thiazolidinedione analogues Lapsed on the fee record Ended Mar 5, 2025 · Medium confidence | Lapsed on the fee record | Ended Mar 5, 2025 | Medium confidence |
| US 9,155,729 | Thiazolidinedione analogues Lapsed on the fee record Ended Oct 13, 2023 · USPTO record | Lapsed on the fee record | Ended Oct 13, 2023 | USPTO record |